Cell & Gene Therapy Innovation Speaker
Director, Analytical Development for Gene Therapy
Dr. Marina Feschenko is currently a Principle Scientist at Biogen. She has been with the company for 7.5 years. Marina is a group leader in Bioassay development for gene therapy and biologics drug candidates. She previously worked for Pfizer and Adolor Corporation. Marina holds Ph.D. from Shemyakin Institute of Bioorganic Chemistry in Russia where her work was focused on monoclonal antibody generation and characterization. Dr. Feschenko underwent postdoctoral training in cell biology and signaling at MGH and Harvard Medical School.